Xeris Biopharma Holdings, Inc. (LON:0A8E)
London · Delayed Price · Currency is GBP · Price in USD 6.80
-0.18 (-2.51%)
Feb 12, 2026, 3:59 PM GMT
Xeris Biopharma Holdings Market Cap
Xeris Biopharma Holdings has a market cap or net worth of 840.32 million as of February 12, 2026. Its market cap has increased by 98.58% in one year.
Market Cap
840.32M
Enterprise Value
962.03M
Revenue
197.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.80
Market Cap Chart
Since October 6, 2021, Xeris Biopharma Holdings's market cap has increased from 218.21M to 840.32M, an increase of 285.10%. That is a compound annual growth rate of 36.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 840.32M | -13.17% |
| Dec 31, 2025 | 967.76M | 139.73% |
| Dec 31, 2024 | 403.69M | 58.41% |
| Dec 29, 2023 | 254.83M | 69.77% |
| Dec 30, 2022 | 150.10M | -44.38% |
| Dec 31, 2021 | 269.85M | 23.67% |
| Oct 6, 2021 | 218.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genus | 2.09B |
| Oxford Nanopore Technologies | 1.40B |
| Oxford Biomedica | 998.08M |
| PureTech Health | 312.74M |
| Avacta Group | 260.26M |
| Scancell Holdings | 128.68M |
| Bioventix | 92.74M |
| 4basebio | 91.32M |